- Active rheumatoid arthritis in adult patients,
- Severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis in adult patients.
This product is available in the following presentations:
- 1 pre-filled syringe of 0.15 ml contains 7.5 mg methotrexate SPC
- 1 pre-filled syringe of 0.20 ml contains 10 mg methotrexate SPC
- 1 pre-filled syringe of 0.30 ml contains 15 mg methotrexate SPC
- 1 pre-filled syringe of 0.40 ml contains 20 mg methotrexate SPC
- 1 pre-filled syringe of 0.50 ml contains 25 mg methotrexate SPC
Method of Sale: POM
License Number: PA0623/014/001
Metoject is distributed in the Republic of Ireland by Fannin Ltd in partnership with Medac.(This link will take you to a non-Fannin Ltd. website. Fannin Ltd. does not recommend, endorse or accept liability for sites controlled by third-parties.)
License Holder: Medac, Gesellschaft für klinische Spezialpräparate mbH, Theatersrt. 6, 22880 Wedel, Germany
For any further information please speak to your local Fannin Representative or for a copy of the SPC please contact our medical information department at firstname.lastname@example.org or via phone on 0868394447.
Additional information available on request.
Date of Preparation: December 2019